Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.52%161.47B | 3.64%656.01B | -5.91%146.1B | -10.35%632.99B | -16.66%183.4B | -18.83%148.68B | -8.02%145.63B | 7.45%155.28B | 37.02%706.07B | 22.81%220.06B |
| Cost of revenue | 9.24%108.99B | 4.71%483.17B | -1.67%99.77B | -12.25%461.45B | -11.21%137.14B | -18.17%113.38B | -17.15%109.46B | 0.72%101.46B | 45.43%525.88B | 26.31%154.46B |
| Gross profit | 13.27%52.48B | 0.76%172.84B | -13.90%46.33B | -4.80%171.54B | -29.49%46.26B | -20.88%35.3B | 38.03%36.17B | 22.93%53.81B | 17.23%180.19B | 15.28%65.6B |
| Operating expense | 4.93%32.64B | 2.91%141.96B | 3.04%31.11B | 1.09%137.94B | -4.60%41.08B | 12.15%35.69B | 0.54%30.97B | -1.83%30.19B | 0.44%136.45B | 2.79%43.06B |
| Operating profit | 30.32%19.84B | -8.07%30.89B | -35.55%15.23B | -23.20%33.6B | -77.05%5.17B | -103.09%-395M | 212.91%5.2B | 81.39%23.62B | 144.95%43.74B | 50.13%22.54B |
| Net non-operating interest income (expenses) | -600.00%-49M | -110.85%-14M | -800.00%-7M | 128.29%129M | 173.68%28M | 149.09%54M | 152.27%46M | 100.45%1M | 11.63%-456M | 67.52%-38M |
| Non-operating interest income | 1.77%230M | 8.86%1.06B | 11.33%226M | 94.59%971M | 18.01%249M | 102.34%259M | 188.89%260M | 190.00%203M | 137.62%499M | 263.79%211M |
| Non-operating interest expense | 19.74%279M | 27.20%1.07B | 15.35%233M | -11.83%842M | -11.24%221M | -13.87%205M | -17.05%214M | -3.81%202M | 31.54%955M | 42.29%249M |
| Net investment income | 15.29%1.58B | 63.42%4.49B | 15.48%1.37B | 17.98%2.75B | 115.79%205M | 17.53%1.15B | 120.65%203M | 2.24%1.19B | 4.62%2.33B | 7.95%95M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -6.77%1.01B | 372.03%7.54B | 1.08B | 1.6B | 333M | 1.27B | 0 | 0 | ||
| Income from associates and other participating interests | -5,938.95%-5.74B | -111.61%-95M | -86.67%109M | -21M | 231.17%818M | 818M | ||||
| Special income (charges) | -2.85%-2.31B | -59.45%-2.25B | -563.23%-4.56B | 0 | -141.51%-1.41B | -18.01%-688M | ||||
| Less:Other special charges | ---- | 131.31%729M | ---- | -463.18%-2.33B | 87.34%-10M | --0 | ---- | ---- | --641M | ---79M |
| Less:Write off | ---- | -65.45%1.58B | ---- | 496.22%4.57B | ---- | ---- | ---- | ---- | 31.56%767M | ---- |
| Other non-operating income (expenses) | 40.38%664M | -37.02%2.78B | -45.69%473M | 85.94%4.42B | 210.91%2.08B | -13.45%502M | 21.44%963M | 161.56%871M | 13.42%2.38B | -41.52%669M |
| Income before tax | 27.02%23.05B | -6.24%37.65B | -29.36%18.14B | -15.30%40.15B | -85.61%3.37B | -82.00%2.56B | 290.14%8.55B | 79.64%25.68B | 122.25%47.4B | 48.11%23.39B |
| Income tax | 43.49%6.43B | -5.11%12.19B | -36.75%4.48B | -6.10%12.85B | -77.79%1.54B | -56.41%1.68B | 339.10%2.54B | 78.22%7.09B | 133.08%13.68B | 63.07%6.91B |
| Net income | 21.62%16.61B | -6.78%25.45B | -26.54%13.66B | -19.03%27.3B | -88.90%1.83B | -91.53%877M | 274.93%6B | 80.19%18.6B | 118.13%33.72B | 42.63%16.48B |
| Net income continuous operations | 21.62%16.61B | -6.78%25.45B | -26.54%13.66B | -19.03%27.3B | -88.90%1.83B | -91.54%876M | 274.96%6B | 80.19%18.6B | 118.13%33.72B | 42.62%16.48B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 21.62%16.61B | -6.78%25.45B | -26.54%13.66B | -19.03%27.3B | -88.90%1.83B | -91.53%877M | 274.93%6B | 80.19%18.6B | 118.13%33.72B | 42.63%16.48B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 21.62%16.61B | -6.78%25.45B | -26.54%13.66B | -19.03%27.3B | -88.90%1.83B | -91.53%877M | 274.93%6B | 80.19%18.6B | 118.13%33.72B | 42.63%16.48B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 31.23%172.3 | -3.05%251.78 | -25.78%131.3 | -19.04%259.71 | -88.90%17.4 | -91.54%8.33 | 274.79%57.07 | 80.13%176.91 | 118.74%320.8 | 42.97%156.78 |
| Diluted earnings per share | 31.23%172.3 | -3.05%251.78 | -25.78%131.3 | -19.04%259.71 | -88.90%17.4 | -91.54%8.33 | 274.79%57.07 | 80.13%176.91 | 118.74%320.8 | 42.97%156.78 |
| Dividend per share | 0 | 14.29%80 | 0 | 16.67%70 | 33.33%40 | 0 | 0.00%30 | 0 | 4.35%60 | 0.00%30 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |